Showing 1 posts of 1 posts found.
MSD (NYSE: MRK) has announced that the US Food and Drug Administration has accepted for review the biologics license application …
MHRA awards Innovation Passports to liver cancer and dementia medicines
Scottish NHS hospital adopts light-activated therapy to reduce surgical infections
Manchester launches nurse-led clinic to improve kidney transplant outcomes
Androlabs and Majorelle expand testosterone therapy into France
Promatix secures Innovate UK funding to advance bispecific ADC programme